Juvena Therapeutics
Juvena Therapeutics develops biologic drug candidates by identifying and engineering human stem cell-secreted proteins into therapies that aim to restore tissue homeostasis and improve muscle and metabolic function. It uses a proprietary, AI-enabled discovery platform that maps the therapeutic potential of the secretome to disease phenotypes and advances selected proteins into engineered biologic medicines. The company’s pipeline includes engineered proteins for muscle regeneration and metabolic indications, with its lead candidate being evaluated in clinical studies for muscle-related disease. Juvena collaborates with partners to expand discovery efforts and explore new therapeutic targets using its computational and biological capabilities.
Domain
juvenatherapeutics.com
Country
United StatesIndustry
BiopharmaEmployees
11-50
Last Funding
$33.5M
Founded
2016
Tech Stack (17 technologies)
Frequently Asked Questions
What technologies does Juvena Therapeutics use?+
Juvena Therapeutics uses 17 technologies including Elementor, WordPress, core-js.
What industry is Juvena Therapeutics in?+
Juvena Therapeutics operates in the Biopharma industry.
Where is Juvena Therapeutics based?+
Juvena Therapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026